A Cohort Study on Biomarkers of Hypertension in Guangdong Province(GDP Study)

Establishing Biobank in a Cohort Study for Hypertensive Patients in Guangdong Province(GDP Study)

Hypertension is the most common chronic diseases and a most important risk factor for cardiovascular and cerebrovascular diseases, and also a substantial public health problem. The purpose of the study is to investigate the association between biomarkers and adverse outcomes in patients with hypertension.

Study population includes subjects who are hypertension, of any race or ethnicity, 18 or older years of age, and have provided written informed consent to provide whole blood specimens at one or more study visits.

Physical examination, questionnaire survey and biological sample collection will be conducted at baseline and the incidence of all-cause and cardiovascular mortality will be investigated during follow-up.

Inclusion Criteria:

• ≥18 years old
• In accordance with the diagnosis of hypertension (including Blood pressure ≥140/90mmHg and/or taking antihypertensive drugs and/or self-reported hypertension)

Exclusion Criteria:

• <18 years old
• Unsigned informed consent
• Pregnant Women and Lactation